NAV3/23/2017 Chg.-2.4200 Type of yield Investment Focus Investment company
515.0500EUR -0.47% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.57 6.12 6.42 -1.06 3.16 -11.73 4.92 5.03 -
2010 4.64 4.78 5.80 0.08 -5.05 -3.26 -3.14 0.42 4.28 4.50 1.74 4.27 +19.88%
2011 -5.00 -0.58 -1.77 3.43 3.21 -1.63 -1.22 -13.48 -0.20 1.92 4.02 6.76 -5.94%
2012 12.44 -0.50 3.77 0.96 6.42 1.08 6.96 -0.39 3.53 -9.25 4.57 -1.92 +29.46%
2013 4.41 5.53 9.71 6.48 4.70 -4.20 12.28 -2.09 6.27 -3.63 8.04 -0.23 +56.68%
2014 12.36 4.08 -10.71 -4.63 4.48 8.14 1.15 13.08 3.01 11.02 3.10 2.31 +55.24%
2015 15.70 6.35 4.96 -7.88 12.24 -2.01 2.87 -12.82 -12.03 10.61 7.05 -1.90 +19.90%
2016 -22.80 -5.60 -0.37 3.47 6.31 -9.21 12.44 -2.44 1.99 -11.88 12.34 -3.40 -22.44%
2017 4.88 9.03 -3.10 - - - - - - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 21.57% 28.57% 27.69% 30.72% 27.14%
Sharpe ratio 2.87 0.17 0.61 0.49 0.87
Best month +9.03% +12.34% +12.44% +15.70% +15.70%
Worst month -3.40% -11.88% -11.88% -22.80% -22.80%
Maximum loss -7.21% -19.45% -19.95% -44.38% -44.38%
Outperformance +3.81% - +2.00% +5.38% +56.58%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 441.7700 +12.92% +20.84%
BB Adamant Biotech I EUR reinvestment 548.5000 +17.36% +54.20%
BB Adamant Biotech I CHF reinvestment 386.4500 +15.15% +35.26%
BB Adamant Biotech I GBP reinvestment 372.7300 - -
BB Adamant Biotech B USD reinvestment 416.3600 +12.09% +18.19%
BB Adamant Biotech B CHF reinvestment 362.2600 +14.30% +32.29%
BB Adamant Biotech B EUR reinvestment 515.0500 +16.50% +50.82%

Performance

YTD  
+10.80%
6 Months  
+2.24%
1 Year  
+16.50%
3 Years  
+50.82%
5 Years  
+183.42%
Since start  
+313.98%
Year
2016
  -22.44%
2015  
+19.90%
2014  
+55.24%
2013  
+56.68%
2012  
+29.46%
2011
  -5.94%
2010  
+19.88%